A new wave of metabolic disease drugs beyond GLP-1 agonists is emerging to address the unmet needs of patients.

Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.

Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies.

Psychiatry is often treated as separate to the rest of medicine. It's time to bring psychiatry into the era of precision medicine.

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future.

Today, AAVantgarde Bio raises $141 million (€122 million) in a series B round to advance its gene therapy programs for inherited eye diseases, marking one of Europe’s largest private financings in ...

Jeff Blaney, PhD is Sr. Director of Discovery Chemistry at Genentech, where he leads research efforts in computational and medicinal chemistry with a focus on integrating AI and data-driven methods ...